Jiangsu Nhwa Pharmaceutical Co Ltd Cash Flow Quality Index
Jiangsu Nhwa Pharmaceutical Co Ltd cash flow quality index. Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Cash Flow Quality Index of 1.05x as of September 2025. Operating cash flow of CN¥425.83 Million exceeds net income of CN¥405.55 Million, indicating high earnings quality where cash backs reported profits. See Jiangsu Nhwa Pharmaceutical Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Cash flow quality index of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025. Historical Cash Flow Quality Index for Jiangsu Nhwa Pharmaceutical Co Ltd across 21 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Jiangsu Nhwa Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Jiangsu Nhwa Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2005–2025)
Jiangsu Nhwa Pharmaceutical Co Ltd cash flow quality index by year from 2005 to 2025. Year-by-year earnings quality comparison for Jiangsu Nhwa Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jiangsu Nhwa Pharmaceutical Co Ltd cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.02x | CN¥1.08 Billion | CN¥1.06 Billion | ▲ +27.0% |
| 2024 | 0.80x | CN¥916.13 Million | CN¥1.14 Billion | ▼ -17.6% |
| 2023 | 0.97x | CN¥1.01 Billion | CN¥1.03 Billion | ▼ -0.3% |
| 2022 | 0.98x | CN¥861.02 Million | CN¥880.39 Million | ▲ +11.3% |
| 2021 | 0.88x | CN¥701.12 Million | CN¥798.02 Million | ▼ -48.8% |
| 2020 | 1.72x | CN¥1.25 Billion | CN¥727.10 Million | ▲ +268.7% |
| 2019 | 0.47x | CN¥305.97 Million | CN¥657.07 Million | ▼ -40.2% |
| 2018 | 0.78x | CN¥404.52 Million | CN¥519.16 Million | ▼ -32.0% |
| 2017 | 1.15x | CN¥452.35 Million | CN¥394.63 Million | ▲ +28.1% |
| 2016 | 0.89x | CN¥277.14 Million | CN¥309.74 Million | ▲ +13.2% |
| 2015 | 0.79x | CN¥204.24 Million | CN¥258.35 Million | ▲ +9.2% |
| 2014 | 0.72x | CN¥160.24 Million | CN¥221.25 Million | ▼ -35.7% |
| 2013 | 1.13x | CN¥194.33 Million | CN¥172.49 Million | ▲ +0.9% |
| 2012 | 1.12x | CN¥154.16 Million | CN¥138.13 Million | ▲ +44.9% |
| 2011 | 0.77x | CN¥81.08 Million | CN¥105.28 Million | ▼ -6.4% |
| 2010 | 0.82x | CN¥61.79 Million | CN¥75.11 Million | ▼ -28.2% |
| 2009 | 1.15x | CN¥61.27 Million | CN¥53.50 Million | ▼ -1.9% |
| 2008 | 1.17x | CN¥46.50 Million | CN¥39.82 Million | ▼ -36.7% |
| 2007 | 1.84x | CN¥48.55 Million | CN¥26.32 Million | ▼ -11.1% |
| 2006 | 2.08x | CN¥30.99 Million | CN¥14.93 Million | ▲ +251.9% |
| 2005 | 0.59x | CN¥8.84 Million | CN¥14.99 Million | — |